Walleye Trading
LPCN icon

Walleye Trading’s Lipocine LPCN Stock Holding History

Walleye Trading’s Portfolio LPCN Stock Details LPCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-6
Closed -$44 – 5211
2022
Q3 		$0 Hold
6
– – ﹤0.01% 5305
2022
Q2 		$0 Hold
6
– – ﹤0.01% 5435
2022
Q1 		$0 Buy
+6
New +$126 ﹤0.01% 5648
2015
Q4 		– Sell
-41
Closed -$8K – 5494
2015
Q3 		$8K Sell
41
-41
-50% -$9.49K ﹤0.01% 4464
2015
Q2 		$12K Buy
+82
New +$10.2K ﹤0.01% 4231

Other funds holding LPCN

EWA
EP Wealth Advisors Torrance, California $20.3B AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WE
Wealth Effects Boston, Massachusetts $282M AUM 62.81% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Walleye Trading's LPCN Position: Q4 2022 in Review

Walleye Trading sold out of Lipocine (LPCN) in Q4 2022, closing a stake of 6 shares — an estimated $44 sold.

Walleye Trading first reported a position in LPCN in Q2 2015 and held it in 5 quarters. The position peaked at $12K in Q2 2015. 49 funds tracked by Wall St. Rank hold LPCN as of Q4 2022.

  • Walleye Trading reported no remaining Lipocine position as of Q4 2022 after selling out during the quarter.
  • Walleye Trading sold 6 Lipocine shares in Q4 2022, an estimated $44.
  • Walleye Trading first reported a position in Lipocine in Q2 2015 and held it in 5 quarters.
  • Walleye Trading's Lipocine position peaked at $12K in Q2 2015.
  • 49 funds tracked by Wall St. Rank held Lipocine as of Q4 2022.

Based on Walleye Trading's 13F filing for Q4 2022, filed 14 Feb 2023.